Endoscopy Procedures Estimates Market Report: Market Size & Forecast 2026

The global endoscopy procedures market represents the cumulative economic activity tied to diagnostic and therapeutic endoscopic interventions performed in hospitals, ambulatory surgical centers, and specialty clinics. Valued at roughly $45.84 billion in 2025, the market is on a clear upward trajectory driven by clinical demand and technological progress. Adjacent device and equipment markets are likewise expanding, with most commercial trackers estimating procedure-related revenue growth in the mid-single to high-single-digit range through the early 2030s.

• •Market valued at $45.84 billion in 2025 with a 6.27% CAGR forecast.
• •Procedures span gastrointestinal, urological, pulmonary, gynecological, and ENT specialties.
• •Adoption is shifting from inpatient surgical suites to outpatient ambulatory centers.

Aging populations in North America, Europe, and parts of Asia are increasing the prevalence of conditions such as colorectal cancer, gastroesophageal reflux disease, and benign prostatic hyperplasia, all of which rely heavily on endoscopic diagnosis and treatment. Parallel investment in screening programs, including broader insurance coverage for colonoscopy and upper endoscopy, is expanding the addressable patient pool. Improvements in device miniaturization, high-definition imaging, and single-use endoscopes are reducing cross-contamination risk and enabling procedures in lower-acuity settings.

• •Rising incidence of GI cancers and chronic gastrointestinal disease.
• •Expansion of reimbursement for routine cancer screening endoscopies.
• •Technology upgrades including 4K imaging, AI-assisted polyp detection, and disposable scopes.

The market segments by procedure type into gastrointestinal endoscopy, urology, pulmonology, gynecology, ENT, and neurology, with gastrointestinal procedures representing the largest share due to colonoscopy and gastroscopy volumes. By end user, hospitals remain the dominant setting, although ambulatory surgical centers and specialty clinics are growing faster as payers and providers favor cost-effective outpatient care. Geographically, North America leads in revenue per procedure due to higher reimbursement and technology adoption, while Asia-Pacific is the fastest-growing region on the back of expanding healthcare infrastructure and rising disposable income.

• •Gastrointestinal endoscopy is the largest procedure category globally.
• •Ambulatory surgical centers are the fastest-growing end-user segment.
• •Asia-Pacific is expanding faster than North America and Europe in absolute volume.

What are the recent trends and outlook?

Artificial intelligence is moving from pilot programs into routine clinical use, with computer-aided detection of polyps during colonoscopy becoming one of the most commercially visible applications. Sustainability and infection control concerns are accelerating the adoption of disposable endoscopes in select procedural categories. Over the forecast horizon, demand is expected to remain resilient, supported by demographic trends, expanded screening guidelines, and continued migration of procedures to outpatient settings.

• •AI-enabled polyp detection is becoming a standard feature in new colonoscopy systems.
• •Disposable endoscopes are expanding in bronchoscopy, urology, and ENT.
• •Procedure volumes are shifting from hospitals to ambulatory surgical centers.